Article Text

Download PDFPDF
Association of smoking and electronic cigarette use with wheezing and related respiratory symptoms in adults: cross-sectional results from the Population Assessment of Tobacco and Health (PATH) study, wave 2
  1. Dongmei Li1,
  2. Isaac K Sundar2,
  3. Scott McIntosh3,
  4. Deborah J Ossip3,
  5. Maciej Lukasz Goniewicz4,
  6. Richard J O’Connor4,
  7. Irfan Rahman2
  1. 1Department of Clinical & Translational Research, University of Rochester Medical Center, Rochester, New York, USA
  2. 2Department of Environmental Medicine, University of Rochester Medical Center, Rochester, New York, USA
  3. 3Department of Public Health Sciences, University of Rochester Medical Center, Rochester, New York, USA
  4. 4Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA
  1. Correspondence to Dr Dongmei Li, Department of Clinical & Translational Research, University of Rochester Medical Center, Rochester, NY 14642-0708, USA; Dongmei_Li{at}urmc.rochester.edu

Footnotes

  • Patient consent for publication Not required.

  • Contributors DL, IR, IKS: conceived and designed the study. DL: analysed the data. DL, IR, IKS, SM, DJO, MLG and RJO: wrote and edited the manuscript.

  • Funding This study was supported by the grants from National Institute of Health NIH 1R01HL135613-(IR) and from the WNY Center for Research on Flavored Tobacco Products (CRoFT) under cooperative agreement U54CA228110. DL’s time is supported by the University of Rochester CTSA award number UL1 TR002001 from the National Center for Advancing Translational Sciences of the National Institutes of Health.

  • Disclaimer The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration (FDA).

  • Competing interests MLG received a research grant from Pfizer and served as a member of advisory board to Johnson & Johnson, manufacturers of smoking cessation medications.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement The PATH wave 2 data can be downloaded from the National Addiction & HIV Data Archive Program (NAHDAP) website public user files (https://www.icpsr.umich.edu/icpsrweb/NAHDAP/studies/36231/datadocumentation).

View Full Text

Statistics from Altmetric.com

Footnotes

  • Patient consent for publication Not required.

  • Contributors DL, IR, IKS: conceived and designed the study. DL: analysed the data. DL, IR, IKS, SM, DJO, MLG and RJO: wrote and edited the manuscript.

  • Funding This study was supported by the grants from National Institute of Health NIH 1R01HL135613-(IR) and from the WNY Center for Research on Flavored Tobacco Products (CRoFT) under cooperative agreement U54CA228110. DL’s time is supported by the University of Rochester CTSA award number UL1 TR002001 from the National Center for Advancing Translational Sciences of the National Institutes of Health.

  • Disclaimer The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration (FDA).

  • Competing interests MLG received a research grant from Pfizer and served as a member of advisory board to Johnson & Johnson, manufacturers of smoking cessation medications.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement The PATH wave 2 data can be downloaded from the National Addiction & HIV Data Archive Program (NAHDAP) website public user files (https://www.icpsr.umich.edu/icpsrweb/NAHDAP/studies/36231/datadocumentation).

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.